IBI (Istituto Biochimico Italiano G. Lorenzini Spa) is a leading international biopharmaceutical company that has been operating since 1918. Specializing in aseptic manufacturing of Injectable Medicinal Products, IBI has established direct commercial presence in the UK, Germany, and Italy, while also exporting through alliances to more than 20 countries worldwide, including the US, Australia, and Europe. IBI offers comprehensive CDMO services, including advanced formulation, process development, and GMP manufacturing of sterile finished products. Their expertise extends to developing solutions and freeze-dried powders for both chemical and biotech active ingredients, such as small molecules, monoclonal antibodies, recombinant proteins, oligonucleotides, and nanoparticle technologies.
 
IBI is certified by FDA, AIFA (EU), EDQM, TGA.

More information: www.ibi-lorenzini.com
Business Development: bd@ibi-lorenzini.com

• GMP production for biological medicinal products (active substance from CHO cell culture, peptides, monoclonal antibodies)
• GMP production of sterile drug products 
• GMP production of sterile API and finished products
• CDMO and GMP production for orals, topicals, injectables 
• Aseptic filling of injectable medicinal products
• Micro and nanoparticles formulations aimed to delivery of different classes of active molecules
• Pharmaceutical development
• Analytical validations, stability testing 
• MA and IMP registration and Batch Release services
• Investigational Medicinal Product production


Biotechnology

Pharmaceutical

IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.

IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.'s headquarters in Aprilia, Italy

People (10)

Jobs (0)

Other offices